Indeed, treatments exert a selective pressure favoring the expansion of TP53-mutated/deleted clones; despite TP53 restoration in tumors affects cancer maintenance, no specific therapies have been developed to effectively overcome TP53 mutated tumors. The gene discussed is TP53; the disease is cancer.